<DOC>
	<DOC>NCT00310817</DOC>
	<brief_summary>To compare the functional immune response 28 days after administration of one dose of Men ACWY-CRM conjugate vaccine without adjuvant (MenACWY-CRM(Ad-)) with that of a Men ACWY polysaccharide (PS) vaccine</brief_summary>
	<brief_title>Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis, Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>healthy 12&lt;60 month old children; subjects who have previously received any meningococcal vaccine subjects with any serious acute or chronic progressive disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>meningitis</keyword>
	<keyword>children</keyword>
	<keyword>vaccine</keyword>
</DOC>